| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, CMO | CMO, Hematology
2 companies
Huang Jane is a President, CMO at PRLD with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 53 sells.
Estimated insider holdings value: $402K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2021 | ONC Beone Medicines Ltd. | CMO, Hematology | Sell | 469 | $325.66 | $152,733.04 | -100% | +19.7% | -58.9% | |
| Jun 7, 2021 | ONC Beone Medicines Ltd. | CMO, Hematology | Sell | 603 | $351.55 | $211,985.55 | -100% | +0.7% | -55.1% | |
| Jun 1, 2021 | ONC Beone Medicines Ltd. | CMO, Hematology | Sale+OE | 2,040 | $357.98 | $730,280.79 | -38.6% | -17.8% | -62.1% | |
| Apr 29, 2021 | ONC Beone Medicines Ltd. | CMO, Hematology | Sale+OE | 1,500 | $354.92 | $532,386.99 | -26.3% | -12.2% | -55.1% | |
| Mar 29, 2021 | ONC Beone Medicines Ltd. | CMO, Hematology | Sale+OE | 1,500 | $324.00 | $485,992.55 | -36.1% | +10.7% | -35.9% | |
| Feb 26, 2021 | ONC Beone Medicines Ltd. | CMO, Hematology | Sale+OE | 1,500 | $320.73 | $481,098.99 | -25.9% | - | - | |
| Jan 29, 2021 | ONC Beone Medicines Ltd. | CMO, Hematology | Sale+OE | 1,500 | $322.99 | $484,492.15 | -26.3% | - | - | |
| Dec 29, 2020 | ONC Beone Medicines Ltd. | CMO, Hematology | Sale+OE | 1,500 | $249.13 | $373,690.01 | -27.3% | - | - | |
| Nov 30, 2020 | ONC Beone Medicines Ltd. | CMO, Hematology | Sale+OE | 1,500 | $267.82 | $401,722.52 | -17.5% | - | - | |
| Oct 29, 2020 | ONC Beone Medicines Ltd. | CMO, Hematology | Sale+OE | 1,500 | $300.06 | $450,093.01 | -81.6% | - | - |